The role of the serotonin (5-HT) system in the neurobiology and treatment of panic disorder (PD) remains unproven. Previously we detected lower brain 5-HT transporter (SERT) availability in PD, but the findings were preliminary and mainly limited to female patients. The aim of this study was to assess non-displaceable brain SERT binding potential (BPND) in male and female patients with PD. The SERT BPND was measured in groups of patients with PD (five males and six females) and matched healthy control subjects (12 males and 12 females) using positron emission tomography (PET) and [11C]MADAM tracer. SERT BPND were significantly higher in 13 of 20 studied brain regions, including several cortical and raphe areas, but lower in the hippocampus in males with PD as compared with healthy males. No significant differences in SERT BPND were observed between female patients and controls. The results suggest gender-dependent regional differences in brain SERT availability and converge with previous PET findings of reduced 5-HT1A receptor binding in similar brain areas in PD. Distinctive functioning of the 5-HT system in males and females may underlie certain gender-dependent differences in expressions of PD.
BenjaminYHochbergY (1995) Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol57: 289–300.
2.
BhagwagarZMurthyNSelvarajSHinzRTaylorMFancyS (2007) 5-HTT binding in recovered depressed patients and healthy volunteers: a positron emission tomography study with [11C]DASB. Am J Psychiatry164: 1858–1865.
3.
CannonDMIchiseMRollisDKlaverJMGandhiSKCharneyDS (2007) Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorder. Biol Psychiatry62: 870–877.
4.
DeakinJFWGraeffFG (1991) 5-HT and mechanisms of defence. J Psychopharmacol5: 305–315.
5.
FrankleWGLombardoINewASGoodmanMTalbotPSHuangY (2005a) Brain serotonin transporter distribution in subjects with impulsive aggressivity: a positron emission study with [11C]McN 5652. Am J Psychiatry162: 915–923.
6.
FrankleWGNarendranRHuangYHwangDRLombardoICangianoC (2005b) Serotonin transporter availability in patients with schizophrenia: a positron emission tomography imaging study with [11C]DASB. Biol Psychiatry57: 1510–1516.
7.
FristonKJHolmesAPWorsleyKJPolineJPFrithCFrackowiakRS (1995) Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Mapp2: 189–210.
8.
FujimuraYYasunoFFarrisALiowJSGeraciMDrevetsW (2009) Decreased neurokinin-1 (substance P) receptor binding in patients with panic disorder: positron emission tomographic study with [18F]SPA-RQ. Biol Psychiatry66: 94–97.
9.
GoddardAWCharneyDS (1997) Toward an integrated neurobiology of panic disorder. J Clin Psychiatry58: 4–11.
10.
GormanJMKentJMSullivanGMCoplanJD (2000) Neuroanatomical hypothesis of panic disorder, revised. Am J Psychiatry157: 493–505.
11.
GraeffFGDel-BenCM (2008) Neurobiology of panic disorder: from animal models to brain neuroimaging. Neurosci Biobehav Rev32: 1326–1335.
12.
GunnRNLammertsmaAAHumeSPCunninghamVJ (1997) Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. Neuroimage6: 279–287.
13.
HalldinCLundbergJSóvágóJGulyásBGuilloteauDVercouillieJ (2005) [(11)C]MADAM, a new serotonin transporter radioligand characterized in the monkey brain by PET. Synapse58: 173–183.
14.
HamiltonM (1959) The assessment of anxiety states by rating. Br J Med Psychol32: 50–55.
15.
HammoudDAEndresCJHammondEUzunerOBrownANathA (2010) Imaging serotonergic transmission with [11C]DASB-PET in depressed and non-depressed patients infected with HIV. Neuroimage49: 2588–2595.
16.
HanDHRenshawPFDagerSRChungAHwangJDanielsMA (2008) Altered cingulate white matter connectivity in panic disorder patients. J Psychiatr Res42: 399–407.
17.
HaslerGNugentACCarlsonPJCarsonREGeraciMDrevetsWC (2008) Altered cerebral gamma-aminobutyric acid type A-benzodiazepine receptor binding in panic disorder determined by [11C]flumazenil positron emission tomography. Arch Gen Psychiatry65: 1166–1175.
18.
HirvonenJAaltoSLummeVNågrenKKajanderJVilkmanH (2003) Measurement of striatal and thalamic dopamine D2 receptor binding with 11Craclopride. Nucl Med Commun24: 1207–1214.
19.
HirvonenJJohanssonJTeräsMOikonenVLummeVVirsuP (2008) Measurement of striatal and extrastriatal dopamine transporter binding with high resolution PET and [11C]PE2I: quantitative modeling and test-retest reproducibility. J Cereb Blood Flow Metab28: 1059–1069.
20.
InnisRBCunninghamVJDelforgeJFujitaMGjeddeAGunnRN (2007) Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab27: 1533–1539.
21.
JovanovicHLundbergJKarlssonPCerinASaijoTVarroneA (2008) Sex differences in the serotonin 1A receptor and serotonin transporter binding in the human brain measured by PET. Neuroimage39: 1408–1419.
22.
KesslerRCBerglundPDemlerOJinRMerikangasKRWaltersEE (2005) Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry62: 593–602.
23.
KesslerRCChiuWTJinRRuscioAMShearKWaltersEE (2006) The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Arch Gen Psychiatry63: 415–424.
24.
KuikkaTPitkänenALepolaUPartanenKVainioPBergströmKA (1995) Abnormal regional benzodiazepine receptor uptake in the prefrontal cortex in patients with panic disorder. Nucl Med Commun16: 273–280.
25.
LammertsmaAAHumeSP (1996) Simplified reference tissue model for PET receptor studies. Neuroimage4: 153–158.
26.
LundbergJOdanoIOlssonHHalldinCFardeL (2005) Quantification of 11C-MADAM binding to the serotonin transporter in the human brain. J Nucl Med46: 1505–1515.
27.
MaliziaALCunninghamVJBellCJLiddlePFJonesTNuttDJ (1998) Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study. Arch Gen Psychiatry55: 715–720.
28.
MaronEShlikJ (2006) Serotonin function in panic disorder: important, but why?Neuropsychopharmacology31: 1–11.
29.
MaronEKuikkaJTShlikJVasarVVanninenETiihonenJ (2004) Reduced brain serotonin transporter binding in patients with panic disorder. Psychiatry Res132: 173–181.
30.
MaronENuttDJKuikkaJTiihonenJ (2010) Dopamine transporter binding in females with panic disorder may vary with clinical status. J Psychiatr Res44: 56–59.
31.
MartinezDSlifsteinMGilRHwangDRHuangYPerezA (2009) Positron emission tomography imaging of the serotonin transporter and 5-HT(1A) receptor in alcohol dependence. Biol Psychiatry65: 175–180.
32.
MassanaGSerra-GrabulosaJMSalgado-PinedaPGastóCJunquéCMassanaJ (2003) Amygdalar atrophy in panic disorder patients detected by volumetric magnetic resonance imaging. Neuroimage19: 80–90.
33.
MatsumotoRIchiseMItoHAndoTTakahashiHIkomaY (2010) Reduced serotonin transporter binding in the insular cortex in patients with obsessive-compulsive disorder: a [11C]DASB PET study. Neuroimage49: 121–126.
34.
MeyerJHHouleSSagratiSCarellaAHusseyDFGinovartN (2004) Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes. Arch Gen Psychiatry61: 1271–1279.
35.
NakamuraKSekineYOuchiYTsujiiMYoshikawaEFutatsubashiM (2010) Brain serotonin and dopamine transporter bindings in adults with high functioning autism. Arch Gen Psychiatry67: 59–68.
36.
NashJRSargentPARabinerEAHoodSDArgyropoulosSVPotokarJP (2008) Serotonin 5-HT1A receptor binding in people with panic disorder: positron emission tomography study. Br J Psychiatry193: 229–234.
37.
NeumeisterABainENugentACCarsonREBonneOLuckenbaughDA (2004) Reduced serotonin type 1A receptor binding in panic disorder. J Neurosci24: 589–591.
38.
NishizawaSBenkelfatCYoungSNLeytonMMzengezaSde MontignyC (1997) Differences between males and females in rates of serotonin synthesis in human brain. Proc Natl Acad Sci USA94: 5308–5313.
39.
OquendoMAHastingsRSHuangYYSimpsonNOgdenRTHuXZ (2007) Brain serotonin transporter binding in depressed patients with bipolar disorder using positron emission tomography. Arch Gen Psychiatry64: 201–208.
40.
ParseyRVHastingsRSOquendoMAHuangYYSimpsonNArcementJ (2006) Lower serotonin transporter binding potential in the human brain during major depressive episodes. Am J Psychiatry163: 52–58.
41.
Praschak-RiederNWilleitMWilsonAAHouleSMeyerJH (2008) Seasonal variation in human brain serotonin transporter binding. Arch Gen Psychiatry65: 1072–1078.
42.
ProtopopescuXPanHTuescherOCloitreMGoldsteinMEngelienA (2006) Increased brainstem volume in panic disorder: a voxel-based morphometric study. Neuroreport17: 361–363.
43.
SekineYOuchiYTakeiNYoshikawaENakamuraKFutatsubashiM (2006) Brain serotonin transporter density and aggression in abstinent methamphetamine abusers. Arch Gen Psychiatry63: 90–100.
44.
SelvarajSHoshiRBhagwagarZMurthyNVHinzRCowenP (2009) Brain serotonin transporter binding in former users of MDMA (‘ecstasy’). Br J Psychiatry194: 355–359.
SheehanDVLecrubierYSheehanKHAmorimPJanavsJWeillerE (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry20: 22–33.
47.
StaleyJKSanacoraGTamagnanGMaciejewskiPKMalisonRTBermanRM (2006) Sex differences in diencephalon serotonin transporter availability in major depression. Biol Psychiatry59: 40–47.
48.
UchidaRRDel-BenCMSantosACAraújoDCrippaJAGuimarãesFS (2003) Decreased left temporal lobe volume of panic patients measured by magnetic resonance imaging. Braz J Med Biol Res36: 925–929.
49.
UchidaRRDel-BenCMBusattoGFDuranFLGuimarãesFSCrippaJA (2008) Regional gray matter abnormalities in panic disorder: a voxel-based morphometry study. Psychiatry Res163: 21–29.
50.
VythilingamMAndersonERGoddardAWoodsSWStaibLHCharneyDS (2000) Temporal lobe volume in panic disorder – a quantitative magnetic resonance imaging study. Psychiatry Res99: 75–82.
51.
YooHKKimMJKimSJSungYHSimMELeeYS (2005) Putaminal gray matter volume decrease in panic disorder: an optimized voxel-based morphometry study. Eur J Neurosci22: 2089–2094.
